Our data showed that when compared to control cells, caspases-8, -9 and -3, and PARP were activated or cleaved, whereas survivin, an inhibitor of apoptosis, was downregulated in NSCLC cells treated by KPT-185 (Figure 5A). The gene discussed is BIRC5; the disease is non-small cell lung carcinoma.